Literature DB >> 15849744

Loss of heterozygosity of 1p in uveal melanomas with monosomy 3.

Thomas Häusler1, Andreas Stang, Gerasimos Anastassiou, Karl-Heinz Jöckel, Stefanie Mrzyk, Bernhard Horsthemke, Dietmar R Lohmann, Michael Zeschnigk.   

Abstract

Gains and losses of chromosomes 1, 3, 6 and 8 are nonrandom chromosomal aberrations in uveal melanoma. Monosomy 3 is the most frequent abnormality and is associated with poor prognosis. To identify regions of allelic loss on the short arm of chromosome 1 and to investigate if these alterations contribute to uveal melanoma progression, we performed microsatellite analysis of 10 loci in 70 uveal melanomas. A total of 51 tumors were obtained from patients with clinical follow-up data, 19 tumors were from recent patients without follow-up. Loss of heterozygosity (LOH) of at least 1 marker was more frequent in tumors with monosomy 3 (40%) than in tumors with disomy 3 (10%). In particular, loss of the entire short arm of chromosome 1 was only observed in tumors with monosomy 3 (p = 0.0001). By comparing the extent of 1p LOH in all tumors with monosomy 3, we were able to define a smallest region of overlap (SRO) of approximately 55 Mb, which is flanked by markers D1S507 and D1S198. On the basis of our data and published cytogenetic data, we propose that 1p31 harbors genes involved in the progression of uveal melanoma with monosomy 3.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15849744     DOI: 10.1002/ijc.21086

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

Review 1.  The genetics of uveal melanoma: an emerging framework for targeted therapy.

Authors:  J William Harbour
Journal:  Pigment Cell Melanoma Res       Date:  2012-02-13       Impact factor: 4.693

Review 2.  Uveal Melanoma Patient-Derived Xenografts.

Authors:  Guillaume Carita; Fariba Némati; Didier Decaudin
Journal:  Ocul Oncol Pathol       Date:  2015-04-09

Review 3.  Metastatic uveal melanoma: biology and emerging treatments.

Authors:  Scott E Woodman
Journal:  Cancer J       Date:  2012 Mar-Apr       Impact factor: 3.360

Review 4.  Molecular pathology of uveal melanoma.

Authors:  S E Coupland; S L Lake; M Zeschnigk; B E Damato
Journal:  Eye (Lond)       Date:  2012-12-07       Impact factor: 3.775

5.  Genetics of uveal melanoma and cutaneous melanoma: two of a kind?

Authors:  Thomas van den Bosch; Emine Kilic; Dion Paridaens; Annelies de Klein
Journal:  Dermatol Res Pract       Date:  2010-06-06

6.  HIC1 modulates uveal melanoma progression by activating lncRNA-numb.

Authors:  Guangcun Cheng; Jie He; Leilei Zhang; Shengfang Ge; He Zhang; Xianqun Fan
Journal:  Tumour Biol       Date:  2016-07-23

7.  Patient-derived xenografts recapitulate molecular features of human uveal melanomas.

Authors:  Cécile Laurent; David Gentien; Sophie Piperno-Neumann; Fariba Némati; André Nicolas; Bruno Tesson; Laurence Desjardins; Pascale Mariani; Audrey Rapinat; Xavier Sastre-Garau; Jérôme Couturier; Philippe Hupé; Leanne de Koning; Thierry Dubois; Sergio Roman-Roman; Marc-Henri Stern; Emmanuel Barillot; J William Harbour; Simon Saule; Didier Decaudin
Journal:  Mol Oncol       Date:  2013-02-26       Impact factor: 6.603

Review 8.  Uveal melanoma: From diagnosis to treatment and the science in between.

Authors:  Chandrani Chattopadhyay; Dae Won Kim; Dan S Gombos; Junna Oba; Yong Qin; Michelle D Williams; Bita Esmaeli; Elizabeth A Grimm; Jennifer A Wargo; Scott E Woodman; Sapna P Patel
Journal:  Cancer       Date:  2016-03-15       Impact factor: 6.860

9.  Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases.

Authors:  Carol L Shields; Arupa Ganguly; Miguel A Materin; Luiz Teixeira; Arman Mashayekhi; Lori Ann Swanson; Brian P Marr; Jerry A Shields
Journal:  Trans Am Ophthalmol Soc       Date:  2007

10.  Anatomic site-specific patterns of gene copy number gains in skin, mucosal, and uveal melanomas detected by fluorescence in situ hybridization.

Authors:  Katharina Glatz-Krieger; Mona Pache; Coya Tapia; Alain Fuchs; Spasenija Savic; Dieter Glatz; Michael Mihatsch; Peter Meyer
Journal:  Virchows Arch       Date:  2006-03-08       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.